This Is MS Multiple Sclerosis Community: Knowledge & Support

Hi friends can anyone help me regarding LDN and AMPYRA. i am about to start the new medications compunded AMPYRA from next week.sametime i am taking LDN.. are there any one taking LDN while on the new medication AMPYRA.I would be very grateful any one let me know can i take LDN when i am taking ampyra,
regards
seeva :roll:

My neuro suggested I try Ampyra and started the prescription process which is a real ordeal. I have to wait for a phone call, then call the compounding pharmacy, then call the other number back plus wait for insurance approval then they mail it to me. Is it worth taking or should I forget about it?

is any body who live in Australia and take Fampyra? i need to know about the cost
thanks

Hi all,

I was wondering if there are any other benefits associated with Fampyra other than improved walking speed. I am not particlarly concerned with my walking speed but with my walking. I really look like a wreck when I walk and can no longer walk unassisted. I also wonder about the side effects that caused a previous poster to cease after just one dose. Being able to walk better would be great but when ...

I have no idea whether my post will be considered appropriate, but I am trying to be creative in finding a way to share a whole month's prescription of Ampyra from which I could tolerate only one pill. I understand why companies cannot take back medications, and while my neurologist's office in a large teaching hospital is sympathetic to all the medications that end up paid for, but not tolerated, there is nothing they can ...

Biogen Idec Inc. said it received conditional approval from the European Commission for Fampyra to improve walking in adult patients with multiple sclerosis or MS who have walking disability. Fampyra is the first treatment that addresses this unmet medical need with demonstrated efficacy in people with all types of MS.

Fampyra can be used alone or in combination with disease modifying therapies, including immunomodulatory drugs.

"With its approval by the European Commission, Fampyra has ...

Our darling Sam was diagnosed with MS at 5 years old, Sam is now 7, he will be 8 in October.

Sam has made his Dad and myself smile again, if you told us that 2 years ago I would never ever have believed it. But Sam has not had a clinical relapse since August 2009, we've had lots of scares and tears but I've learnt MS is so so wierd, you can havesymptoms ...

Acorda Therapeutics, Inc. announced an analysis of pooled clinical trial results showed patients who were responders to Ampyra® (dalfampridine) Extended Release Tablets, 10 mg demonstrated clinically relevant improvements in walking ability as measured by patient self-report on the 12-Item Multiple Sclerosis Walking Scale (MSWS-12), regardless of either their baseline Expanded Disability Status Scale (EDSS) score or baseline walking speed.

The data were presented at the 2011 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, ...

Reversing an earlier decision, European regulators have recommended approving Acorda Therapeutics Inc's (ACOR.O) drug Fampyra, which is designed to improve the walking ability of patients with multiple sclerosis.

Acorda shares jumped 21 percent to $32.33 in premarket trading on Friday.

The European Medicines Agency, which advises the European Commission on whether to approve new drugs, said in a statement it has recommended giving the drug conditional approval.... Read More - ...

The Australian Therapeutic Goods Administration (TGA) has granted approval for Fampyra™, (fampridine) 10 mg Modified Release (MR) tablet, for the symptomatic improvement of walking ability in adult patients with multiple sclerosis (MS) who have shown improvement after eight weeks of treatment.

Fampyra demonstrated efficacy in people with all four majortypes of MS (relapsing remitting, secondary progressive, progressive relapsing and primary progressive). Fampyra can be used alone or with existing MS therapies, including immunomodulator drugs..... ...